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Abstract
Objectives:  Set  the  sensitivity  of  the  histopathological  diagnosis  of  chorioamnionitis  (CAMH)  for
early diagnosis  of  neonatal  sepsis  and  the  relationship  between  histological  chorioamnionitis
and premature  rupture  of  membranes  and  neonatal  sepsis.
Materials  and  methods:  Prospective,  observational  study  and  diagnostic  test  performed  in  the
Neonatology  Service  of  the  ‘‘Dr.  José  Eleuterio  González’’  University  Hospital.  Epidemiological
variables  were  collected  from  mothers  and  newborns.  The  relationship  between  histological
chorioamnionitis  with  premature  rupture  of  membranes  and  early  neonatal  sepsis  was  estab-
lished.
Results: We  recorded  3694  births.  Of  these,  122  patients  were  studied  as  potentially  infected,
of whom  37  patients  were  excluded  (2  by  transfer  to  another  hospital  and  35  by  not  ﬁnding  a
histopathological  study  of  the  placenta).  The  study  included  85  newborns.  Of  these,  43  (50.5%)
developed  clinical  and  laboratory  data  of  early  neonatal  sepsis,  the  rest  (n  =  42,  49.5%)  were
healthy newborns.  The  sensitivity  of  histological  chorioamnionitis  with  premature  rupture  of
membranes  (PRM)  of  more  than  24  h  was  81%  for  neonatal  sepsis  and  51%  without.  The  risk
factors for  neonatal  sepsis  were:  Mother  with  infection  (p  <  0.001),  weight  <1500  g  (<0.001),
gestational  age  <28  weeks  (<0.05),  APGAR  score  <6  in  5  min  (p  <  0.05).
Conclusions:  Placental  chorioamnionitis  with  premature  rupture  of  membranes  >  24  h  has  an
81% sensitivity  for  neonatal  sepsis.  A  newborn  with  histological  chorioamnionitis  has  a  51%
sensitivity  for  neonatal  sepsis.
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Introduction
Chorioamnionitis  (CAM)  is  the  inﬂammation  of  the  amnio-
chorionic  membrane  and  the  most  frequent  cause  of
premature  delivery.  Chorioamnionitis  can  be  clinically
deﬁned  based  on  maternal  symptoms  which  include  fever,
abdominal  pain,  abnormal  vaginal  ﬂow  and  leukocytosis.  It
can  also  be  histologically  deﬁned  with  evidence  of  inﬂam-
mation  and  necrosis  in  the  entire  chorionic  plate  and
amnion.  Chorioamnionitis  is  linked  to  signiﬁcant  maternal
and  neonatal  morbidity  and  mortality  rates.1--11 It  often
occurs  through  an  ascending  and  multi-bacterial  infection.
CAM  can  cause  fetal  inﬂammatory  response  syndrome,  which
brings  along  greater  risks  of  periventricular  leukomalacia
(PVL),  cerebral  palsy  and  chronic  pulmonary  disease.12--15
The  objective  of  this  study  was  to  correlate  histological
chorioamnionitis  sensitivity  with  neonatal  sepsis  and  pre-
mature  rupture  of  membranes  (PRM).
Materials and methods
An  observational,  prospective  study  and  a  diagnostic  test
were  conducted  at  the  neonatal  service  of  the  ‘‘Dr.  Jose  E.
Gonzalez’’  University  Hospital  of  the  Autonomous  University
of  Nuevo  León,  from  August  1st,  2012  to  July  31st,  2013.  This
study  was  accepted  by  the  institution’s  Ethics  Committee
with  the  folio  no.  NE12-002.
The  study  included  those  patients  admitted  to  the  Neona-
tal  Intermediate  and  Intensive  Care  Units  with  a  diagnosis
of  potentially  infected,  with  a  history  of  premature  rup-
ture  of  membranes  with  18  h  of  evolution  or  longer,  maternal
fever,  warm  and/or  fetid  uterine  cavity,  and  a  histopatholog-
ical  study  of  the  placenta.  On  the  other  hand,  we  excluded
potentially  infected  newborns  born  in  a  different  hospi-
tal  and,  lastly,  we  eliminated  patients  who  did  not  have  a
histopathological  study  of  the  placenta.
The  sample  was  made  by  convenience  and  included  the
potentially  infected  patients.  After  looking  at  in-hospital
clinical  evolution  the  patients  were  divided  into  two  groups
for  analytical  comparison:  the  ﬁrst  group  included  patients
with  neonatal  sepsis  and  the  second  group  was  a  control
group  which  included  healthy  patients.
Studied variables
Maternal  history
Maternal  age,  divided  into,  <18  years  old,  19--30  years  old
and  >30  years  old;  health,  subdivided  into  healthy  moth-
ers  and  history  of  threatened  abortion,  premature  delivery,
infections,  preeclampsia,  eclampsia,  gestational  diabetes,
chorioamnionitis,  antepartum  hemorrhages  and  premature
rupture  of  membranes,  with  a  subdivision  of  time  intervals
of:  18--24  h,  25--48  h,  49--72  h  and  >72  h.
Variables  of  newbornsWeight  at  birth  in  grams,  divided  into  <1000,  1000--1500,
1501--2500,  2501--4000  and  >4000;  gestational  age  in  weeks
according  to  the  following  intervals:  <28  weeks,  28--33
(
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n
are  of  membranes  11
eeks,  34--36  weeks,  37--42  and  >42  weeks.  Trophism
ccording  to  a  percentile  in  weight  divided  into;  adequate
or  gestational  age,  small  for  gestational  age  and  large  for
estational  age;  male  or  female,  and  APGAR  score  at  5  min
ivided  as  follows:  0--3  points,  4--6  points  and  7--10  points.
Qualitative  variables  were  used  in  the  statistical  anal-
sis.  Hypothesis  tests  were  the  following:  chi  square  test
non-parametric),  an  alpha  value  of  0.05  was  used  and  the
ull  hypothesis  was  rejected  when  the  critical  value  was  less
han  0.05.  For  those  variables  representing  statistically  sig-
iﬁcant  numbers,  the  odds  ratios  were  obtained,  and  when
hey  were  based  on  a  conﬁdence  interval  of  95%,  risk  factors
upporting  the  alternative  hypothesis  and  protective  factors
ere  obtained.  Sensitivity  and  speciﬁcity  were  obtained,  as
ell  as  positive  and  negative  predictive  values  using  a  2  ×  2
ontingency  table  where  the  predictive  or  ‘‘independent’’
ariable  was  the  premature  rupture  of  membranes  and  the
utcome  or  ‘‘dependent’’  variable  was  neonatal  sepsis.
Sensitivity  and  speciﬁcity  were  obtained,  as  well  as  pos-
tive  and  negative  predictive  values  using  chorioamnionitis
ith  sepsis  as  a  predictive  variable  and  the  ruptured  sac
24  h  as  another  dependent  variable.
esults
here  were  3694  births  in  the  studied  period.  Of  these,  122
atients  were  studied  as  potentially  infected.  37  patients
ere  excluded  (2  because  they  were  moved  to  a  different
ospital  and  35  because  they  did  not  have  the  histopatholog-
cal  study  of  the  placenta).  In  the  end,  the  studied  sample
as  85  newborns.  Out  of  these,  50.5%  (n  =  43)  developed
linical  and  laboratory  data  of  early  neonatal  sepsis,  the
est  49.5%  (n  =  42)  were  reported  as  healthy.
When  comparing  maternal  history  in  both  groups  (neona-
al  sepsis  vs.  healthy)  the  ﬁndings  were  the  following:
aternal  age  of  the  study  groups  was  the  same,  with  the
ighest  number  of  mothers  in  the  19--35  years  old  group.
egarding  maternal  health  during  pregnancy,  mothers  of
he  neonatal  sepsis  group  had  a  higher  morbidity  p  <  0.001,
mong  which  infections  standout  (23%  vs.  4.7%)  p  <  0.05.  The
est  of  the  diseases  registered  without  a  signiﬁcant  number.
egarding  ruptured  sac  time,  in  both  groups,  the  highest
ercentage  was  found  in  rupture  over  72  h,  in  the  statistical
nalysis,  both  groups  were  the  same.  In  prenatal  care,  both
roups  were  similar,  with  86%  of  the  patients  in  the  neonatal
epsis  group  and  90.4%  in  the  healthy  group  (Table  1).
ewborns’  characteristics
hen  comparing  weight  at  birth,  most  patients  with  sep-
is  weighed  under  2500  g  (<0.05).  Regarding  age  groups,
he  <28  weeks  group  had  20.9%  of  newborns  with  sepsis
nd  2.3%  of  the  healthy  ones  (p  <  0.01).  We  identiﬁed  the
argest  group  in  the  28--33  weeks  interval,  with  51.1%  of
he  patients  with  sepsis  and  30.9%  of  the  healthy  ones,  a
on-signiﬁcant  number  compared  with  the  group  of  34--36
eeks  with  9.3%  septic  patients  and  45.2%  healthy  onesp  <  0.001);  gestational  ages  of  37--42  and  more  weeks  were
ithout  signiﬁcant  numbers.  Regarding  trophism,  the  largest
umber  corresponded  to  an  adequate  weight  for  gestational
ge  in  both  groups  (62.7%  and  76.1%,  septic  and  healthy
12  I.  Rodríguez-Balderrama  et  al.
Table  1  Maternal  antecedents.
Neonatal  sepsis
n  =  43  (%)
Healthy
n  =  42  (%)
p
Maternal  age
<18  years  8  (18.6)  7  (16.6)  0.813
19--35 years  30  (69.7)  24  (57.1)  0.226
>35 years  5  (11.6)  11  (26.1)  0.085
Maternal health  during  pregnancy
Healthy  26  (60.4)  36  (85.7)  <0.01
Threat of  abortion  6  (13.9)  3  (7.1)  0.308
Threat of  early  birth 4  (9.3) 6  (14.2)  0.477
Infections 10  (23) 2  (4.7) <0.05
Pre-eclampsia 3  (6.9) 0  (–) 0.080
Gestetional  diabetes  3  (6.9)  0  (–)  0.080
Chorioamnionitis  0  (–)  1  (2.3)  0.307
Antepartum hemorrhage 7  (16.2)  6  (14.2)  0.975
Other 2  (4.6)  2  (4.7)  0.975
Premature rupture  of  membranes
18--24  hrs  5  (11.6)  5  (11.9)  0.970
25--48 hrs  6  (13.9)  10  (23.8)  0.244
49--72 hrs  5  (11.6)  5  (11.9)  0.970
>72 hrs  11  (25.5)  17  (40.4)  0.143
Prenatal control
Yes  37  (86)  38  (90.4)  0.524
Table  2  Newborn  characteristics.
Neonatal  sepsis
n  =  43  (%)
Healthy
n  =  42  (%)
p
Weight  if  the  newborn  in  grams
<1000  10  (23)  1  (2.3)  <0.01
1000--1500 15  (65.2)  5  (11.9)  <0.05
1501--2500 11  (25.2)  21  (50)  <0.05
2501--4000 6  (13.9)  14  (33.3)  <0.05
>4000 1  (2.3)  1  (2.3)  0.981
Gestetional age  in  weeks
<28  9  (20.9)  1  (2.3)  <0.01
28--33 22  (51.1)  13  (30.9)  0.058
34--36 4  (9.3)  19  (45.2)  <0.001
37--42 8  (18.6)  9  (21.4)  0.744
Trophism
AGA 27  (62.7)  32  (76.1)  0.185
BGA 12  (27.9)  8  (19)  0.334
LGA 4  (9.3)  2  (4.7)  0.413
Gender 0.433
Male 23  (53.4)  26  (61.9)
Female 20  (46.5)  16  (38)
APGAR score  <0.05
0--3 0  (--)  0  (--)
4--6 10  (23.2)  2  (4.8)
7--10 33  (76.8)  40  (95.2)
AGA, adequate to gestational age; BGA, below gestational age; LGA, larger than gestational age.
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Table  3  Odds  ratio  (OR)  for  neonatal  sepsis  of  statistically  signiﬁcant  value.
p  RM  IC  95%
Risk  factors
Maternal  infection  <0.001  19.5  3.99--95
Weight <1500  g  <0.001  8.3  2.36--30
Gestational  age  <28
weeks
<0.05  10.8  1.30--29
APGAR <6  at  5  min <0.05 6  1.22--29
Protective factors
Gestational  age
34--36  weeka
<0.01  0.12  0.037--0.409
Healthy colorb <0.01  0.25  0.034--1.89
a Protection factor or 8 to not get sick.
b Protection factor of 4 to not get sick.
Table  4  Chorioamnionitis  with  sepsis  and  PRM  relation  >24  h.
Sensitivity  (%)  Speciﬁcity  (%)  PPV  (%)  NPV  (%)
Chorioamnionitis  and  neonatal  sepsis  51  35  44  41
Chorioamnionitis  and  ruptured  sac  >24  h  81  31  45  71
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respectively),  a  non-signiﬁcant  number.  Male  patients  were
53.4%  of  the  neonates  within  the  sepsis  group  and  61.9%  of
the  healthy  group  (NS).  Regarding  the  APGAR  score,  there
were  more  <6  scores  in  the  sepsis  group  (p  <  0.05)  (Table  2).
The  odds-ratio  (OR)  analysis,  with  a  conﬁdence  level  of
95%,  considering  risk  factors  for  neonatal  sepsis  develop-
ment  present  the  following:  presence  of  maternal  infection
OR  =  19.5,  weight  at  birth  <1500  g  OR  =  8.3,  for  the  gesta-
tional  age  <28  week  group  OR  =  10.8  and  APGAR  <6  at  5  min
OR  =  6.  Protective  factors  to  avoid  getting  sick  are:  gesta-
tional  age  of  34--36  weeks  OR  =  0.12,  which  establishes  a
protective  factor  of  8  and  the  corresponding  variable  of
a  healthy  mother  OR  =  0.25  with  a  protective  factor  of  4
(Table  3).
When  correlating  histological  chorioamnionitis  with  sep-
sis,  we  were  able  to  ﬁnd  a  sensitivity  of  51%  and  when
relating  chorioamnionitis  and  ruptured  sac  >24  h  we  were
able  to  ﬁnd  a  sensitivity  of  81%  with  a  speciﬁcity  of  31%,  a
positive  predictive  value  of  45%  and  a  negative  predictive
value  of  71%  (Table  4).
Discussion
Chorioamnionitis  (or  intra-amniotic  infection)  refers  to  the
inﬂammation  of  the  amniochorionic  membrane  (in  chorion
and  amnion).  It  is  estimated  to  be  present  in  approximately
2--4%  of  full-term  pregnancies,1,2 and  in  approximately
40--70%  of  women  with  premature  deliveries.3,4 CAM  can
be  deﬁned  clinically  based  on  maternal  symptoms,  includ-
ing  fever,  abdominal  pain,  abnormal  vaginal  ﬂow  and
leukocytosis,5--7 as  well  as  histologically,  with  evidence  of
inﬂammation  and  necrosis  in  the  entire  chorionic  plate  and
amnion.1,8
B
(
g NPV, negative predictive value.
Chorioamnionitis  is  linked  to  signiﬁcant  morbidity  and
ortality  maternal  and  neonatal  rates.9 Neonatal  morbidi-
ies  include  a  greater  risk  of  neonatal  sepsis,10 pneumonia,11
nd  neurological  damage.12,13 On  the  other  hand,  chorioam-
ionitis  can  lead  to  fetal  inﬂammatory  response  syndrome,
hich  brings  along  greater  risks  of  periventricular  leuko-
alacia,  cerebral  palsy14,15,34 and  chronic  pulmonary
isease.16,17
The  more  premature  the  child  is,  the  greater  the  prob-
bility  of  detecting  histological  chorioamnionitis.  A  study
ound  that  out  of  those  cases  which  gave  birth  between  21
nd  24  weeks,  67%  showed  evidence  of  infection  and  histo-
ogical  inﬂammation,  compared  to  22%  of  those  who  gave
irth  between  weeks  33  and  36.18 In  our  study,  out  of  a
ample  of  85  patients,  58%  had  histologic  chorioamnionitis
HCAM)  and  of  the  septic  51%  CAMH.
Chorioamnionitis  occurs  more  frequently  as  a  result  of
scending  vaginal  and  cervix  bacteria,  it  is  more  frequently
bserved  as  a  secondary  complication  to  a  prolonged  rup-
ure  of  membranes.19 Less  common  ways  of  infection  include
ematogenous  dissemination  or  transmission  posterior  to  an
nvasive  procedure  (in  other  words,  amniocentesis,  chori-
nic  villus  sampling,  or  other  fetal  procedure).  Bacterial,
iral  and  in  rare  occasions  fungal  agents  have  been  related  to
he  pathogenesis  of  chorioamnionitis  and  premature  deliv-
ry.  Some  of  the  commonly  identiﬁed  pathogens  include
reaplasma  urealyticum, Chlamydia  trachomatis, Neisseria
onorrea,  Mycoplasma  hominis,  group  B  strephtococcus  and
richomonas  vaginalis.  Additional  bacteria  include  gram-
egative  anaerobes,  including  Gardnerella  vaginalis  and
20--22acteroides  spp.
Fungal  organisms,  including  several  Candida  species
Candida  albicans,  Candida  tropicalis  and  Candida
labrata),  have  also  been  associated  with  chorioamnionitis.
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hese  infections  have  been  reported  in  pregnant  women
ith  in  vitro  fertilization,  in  those  with  retained  intrauterine
evices  after  amniocentesis  and  in  those  with  a  prolonged
upture  of  membranes.23--27 Organisms  like  Mycoplasma
re  typically  low  virulence  organisms,  which  explains  why
omen  with  histological  chorioamnionitis  frequently  do  not
resent  clinical  symptoms.27
Aside  from  colonization  with  bacteria  and  virus,  there  are
everal  risk  factors  for  the  development  of  chorioamnionitis.
s  previously  discussed,  prematurity  and  premature  rupture
f  membranes  are  commonly  linked  to  chorioamnionitis.  In
ur  casuistry,  86.5%  of  children  with  neonatal  sepsis  had  a
uptured  sac  of  over  24  h.  In  full-term  babies,  risk  factors
ncluded:  long  duration  of  delivery  and  of  the  rupture  of
he  membrane,  and  nulliparity.28 Additionally,  women  with
arly  rupture  of  membranes  at  term  who  receive  multi-
le  digital  vaginal  tests,  having  a  prolonged  labor  or  with
econium-stained  liquid  have  a  greater  risk  of  developing
horioamnionitis.29 In  our  study,  we  were  able  to  ﬁnd  that
1%  of  children  who  had  ruptured  sac  of  over  24  h  and  pla-
enta  chorioamnionitis  had  neonatal  sepsis.
CAM  can  be  diagnosed  with  the  use  of  histological  or
linical  criteria.  Clinical  diagnosis  is  based  in  local  or  sys-
emic  infection  signs  and  symptoms.  Common  deﬁnition
ncludes  maternal  fever  (fever>37,  5--38 ◦C)  and  one  of
he  following:  abdominal  pain,  uterine  pain,  fetid  vagi-
al  ﬂow,  maternal  tachycardia  (>100  heartbeats/min),  fetal
achycardia  (persistent  elevation  of  fetal  cardiac  frequency
160  heartbeats/min)  and  an  elevated  count  of  maternal
hite  blood  cells  (>15,000  cells/mm3).  The  cut-off  point  for
aternal  fever  varies  through  several  studies.  However,  the
ost  recent  literature  cites  a  value  of  >38 ◦C,  thus  excluding
he  many  women  with  a  low  degree  fever  during  delivery,
hich  is  not  related  to  an  infectious  process.6,30,31
Chorioamnionitis  can  occur  histologically,  and  is  orga-
ized  on  the  base  of  speciﬁc  criteria,  with  the  increase
n  neutrophils  inﬁltration  and  the  development  of  necrosis,
hickening  of  the  amnion  basement  membrane  and  chori-
nic  micro-abscesses  which  are  seen  with  the  increase  of
he  severity  of  the  disease.  Moreover,  fetal  inﬂammatory
esponse  can  progress  from  a  chorionic  vasculitis/umbilical
inﬁltration  of  neutrophils  into  chorionic  or  umbilical  ves-
els)  to  necrotizing  funisitis  (inﬂammation  of  the  umbilical
ords  conjunctive  tissue).8,13 Clinical  diagnosis  of  chorioam-
ionitis,  however,  is  not  always  conﬁrmed  by  histological
r  microbiological  studies.  In  a  study  of  139  pregnancies
ith  clinical  ﬁndings  of  chorioamnionitis,  the  histological
xam  of  the  placenta  did  not  support  the  clinical  diagnosis
n  approximately  a  third  of  the  cases.32 In  our  study,  49%
f  children  with  sepsis  had  a  histologically  normal  placenta.
horioamnionitis,  deﬁned  by  positive  cultures  of  amniotic
iquid,  was  found  in  36%  of  women  with  premature  rupture
f  membranes.33
onclusions1%  of  newborns  with  histologic  chorioamnionitis  had  sepsis.
lacenta  chorioamnionitis  with  premature  rupture  of  mem-
ranes  of  more  than  24  h  has  an  81%  sensitivity  for  a  neonatal
epsis  diagnosis.
1I.  Rodríguez-Balderrama  et  al.
imitations  of  the  study
 A  larger  population  is  required  for  the  ﬁndings  in  our  sam-
ples  to  be  real  for  the  general  population.
 In  this  sample,  it  was  not  possible  to  perform  a  ROC  curve,
which  could  have  been  helpful.
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